Cargando…
Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832014/ https://www.ncbi.nlm.nih.gov/pubmed/35153802 http://dx.doi.org/10.3389/fphar.2022.842512 |
_version_ | 1784648635130052608 |
---|---|
author | Simko, Fedor Baka, Tomas |
author_facet | Simko, Fedor Baka, Tomas |
author_sort | Simko, Fedor |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8832014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88320142022-02-12 Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells Simko, Fedor Baka, Tomas Front Pharmacol Pharmacology Frontiers Media S.A. 2022-01-28 /pmc/articles/PMC8832014/ /pubmed/35153802 http://dx.doi.org/10.3389/fphar.2022.842512 Text en Copyright © 2022 Simko and Baka. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Simko, Fedor Baka, Tomas Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells |
title | Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells |
title_full | Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells |
title_fullStr | Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells |
title_full_unstemmed | Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells |
title_short | Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells |
title_sort | commentary: effect of angiotensin-converting-enzyme inhibitor and angiotensin ii receptor antagonist treatment on ace2 expression and sars-cov-2 replication in primary airway epithelial cells |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832014/ https://www.ncbi.nlm.nih.gov/pubmed/35153802 http://dx.doi.org/10.3389/fphar.2022.842512 |
work_keys_str_mv | AT simkofedor commentaryeffectofangiotensinconvertingenzymeinhibitorandangiotensiniireceptorantagonisttreatmentonace2expressionandsarscov2replicationinprimaryairwayepithelialcells AT bakatomas commentaryeffectofangiotensinconvertingenzymeinhibitorandangiotensiniireceptorantagonisttreatmentonace2expressionandsarscov2replicationinprimaryairwayepithelialcells |